Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03191760
Other study ID # 00975
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 8, 2017
Est. completion date February 18, 2020

Study information

Verified date November 2023
Source VA Puget Sound Health Care System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to see if "Behavioral Activation and Social Engagement for PTSD" (BASE for PTSD), an individual therapy for PTSD, will help Veterans with PTSD 1) through improved understanding of how PTSD affects them, 2) by reducing ways in which they avoid meaningful activity due to PTSD, 3) by enabling them to do more of the things they really care about, and 4) by improving, strengthening, and building up their social supports.


Description:

Posttraumatic stress disorder (PTSD) is a mental health condition that some people develop following exposure to a traumatic event. PTSD often results in a reduction in feelings of connection to other people and changes in views about others, as well as reduced participation in valued activities. Many veterans with PTSD do not seek treatment offered in specialty mental health settings and may forgo treatment of any kind. This study is an open-trial format (no comparison condition) of U.S. military veterans who will participate in a brief psychotherapy treatment for PTSD offered in a Primary Care setting. This is a pilot trial to see if the treatment is effective at reducing symptoms of PTSD and increasing feelings of social support, and an exploratory aim is to see if veterans engage in additional treatment after completing this treatment.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date February 18, 2020
Est. primary completion date February 18, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Veterans who: 1. are currently enrolled in either of the Primary Care Clinics (including Women's Clinic) or Primary Care Mental Health Integration clinic at VA Puget Sound Health Care System - Seattle Division 2. meet criteria for clinical or subclinical PTSD 3. are willing to have therapy sessions audiotaped for the purposes of supervision 4. plan to live in the Seattle area for 6 months following entry into the study Exclusion Criteria: - Veterans who: 1. exhibit the presence of severe mental illness diagnosis (e.g., active psychosis and/or uncontrolled bipolar disorder) 2. have been a psychiatric in-patient admission in the past 30 days 3. have had a suicide attempt in the last 60 days 4. have had a plan or intent to harm self or others in the last 30 days 5. have a behavioral flag in their medical record 6. have had a psychiatric medication dosing or receipt that has changed in the last 30 days 7. are unwilling to provide at least 1 collateral contact 8. have impaired decision making capacity (as measured by evidence in the Computerized Patient Record System record of moderate-severe Traumatic Brain Injury, uncontrolled psychosis, dementia, communication flag, or by clinical judgment in speaking with the participant 9. are prisoners 10. are illiterate or have limited or no English proficiency 11. are terminally ill 12. are currently participating in Cognitive Processing Therapy (CPT) or Prolonged Exposure Therapy (PE)

Study Design


Intervention

Behavioral:
Behavioral Activation
Participants will be asked to attend 6 in-person or phone-mediated therapy sessions lasting approximately 45 minutes per session, to be held in Primary Care settings. Content of therapy sessions includes education about PTSD symptoms, discussion of the role of avoidance in maintaining PTSD symptoms, self-monitoring homework to identify links between activity level and emotions, and homework designed to increase engagement in valued activities, with a focus on increasing social contact and support. If relevant, participants will be instructed in basic communication skills, social skills, and relaxation skills.

Locations

Country Name City State
United States VA Puget Sound Health Care System Seattle Washington

Sponsors (1)

Lead Sponsor Collaborator
VA Puget Sound Health Care System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary PTSD Checklist-Military Version Change in PTSD symptoms baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Primary Medical Outcomes Study Social Support Survey Form and Social Connectedness Scale - Revised Change in social support baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Primary Patient Health Questionnaire-9 Change in Depression symptoms baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Primary Network Orientation Scale Change in social network orientation baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Primary Behavioral Activation for Depression Scale Change in activity level baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Secondary Qualitative assessment Participants' reactions to the treatment will be gathered in qualitative interviews assessing treatment experience, perceptions of treatment focus, engagement with valued activities, social support, therapeutic relationship 12 weeks
Secondary Additional treatment engagement measured via medical record review 16 weeks
Secondary Brief COPE Change in coping strategies baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
Secondary Social Connectedness Scale - Revised (SCS-R) Change in the level of interpersonal closeness related to participants' social environment and the degree of difficulty experienced by participants in sustaining the sense of closeness baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Completed NCT05112003 - Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot N/A
Recruiting NCT04518267 - Anger and Psychotrauma: Data From Military and Civilians
Completed NCT02502604 - Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder N/A
Terminated NCT02234687 - A mGlu2/3 Agonist in the Treatment of PTSD Phase 1
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Completed NCT02213900 - Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy Phase 4
Terminated NCT02520726 - PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims Phase 4
Completed NCT01738308 - The Effects of Healing Touch on Post Operative Pediatric Patients N/A
Completed NCT01437891 - Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF) N/A
Completed NCT01517711 - Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) Phase 4
Completed NCT01998100 - Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01199107 - Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01231711 - Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention Phase 1
Completed NCT00348036 - Group Intervention for Interpersonal Trauma N/A
Completed NCT00838006 - Psychophysiologic Predictors of Post-deployment Mental Health Outcomes N/A
Completed NCT00680524 - Telephone-based Care for OEF/OIF Veterans With PTSD N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00158262 - Effect of Propranolol on Preventing Posttraumatic Stress Disorder Phase 4
Completed NCT00127673 - Comparison of Two Treatments for Post-Traumatic Stress Disorder Phase 3